Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1/A IPO registration
- 1.1 Underwriting Agreement
- 3.3 Articles of Incorporation / Bylaws
- 3.4 Articles of Incorporation / Bylaws
- 3.6 Articles of Incorporation / Bylaws
- 4.2 Form of Warrant Agreement and Warrant
- 4.3 Form of Underwriters Warrant
- 5.1 Opinion of K&L Gates LLP
- 10.4 Endra Life Sciences Inc 2016 Omnibus Incentive Plan to Be In Effect Upon Completion of This Offering
- 10.5 Material Contracts
- 10.6 Material Contracts
- 23.1 Consent of RBSM LLP, Independent Registered Public Accounting Firm
NDRA similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the reference to our firm under the caption “Experts” and the use of our report dated July 15, 2016 (except for the effect of the restatement discussed in Note 3 to the financial statements, for which the date is August 4, 2016), which includes an explanatory paragraph regarding the substantial doubt about the Company’s ability to continue as a going concern, on the financial statements of Endra Life Sciences Inc. which appears in this Registration Statement on Form S-1 Amendment No. 1.
/s/ RBSM LLP
Henderson, NV
December 6, 2016